LEPU BIO-B News

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Dec 5 05:04 ET

LEPU BIO-B: CONTINUING CONNECTED TRANSACTIONCDMO SERVICES FRAMEWORK AGREEMENT

Nov 26 08:40 ET

LEPU BIO-B: ANNOUNCEMENT OFPROPOSED CHANGE OF AUDITOR

Nov 26 08:21 ET

LEPU BIO-B: CONTINUING CONNECTED TRANSACTIONNEW PROCUREMENT FRAMEWORK AGREEMENT

Nov 26 08:15 ET

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 5 02:16 ET

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 6 23:06 ET

LEPU BIO-B: VOLUNTARY ANNOUNCEMENTACCEPTANCE OF THE NEW DRUG APPLICATION AND PRIORITYREVIEW GRANTED BY NMPA TOMRG003 FOR THE TREATMENT OF R/M NPC

Sep 26 20:00 ET

LEPU BIO-B: 2024 Interim Report

Sep 24 04:32 ET

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 4 02:48 ET

LEPU BIO-B: ARTICLES OF ASSOCIATION

Sep 2 05:30 ET

LEPU BIO-B: AMENDMENTS TO THE ARTICLES OF ASSOCIATION

Sep 2 05:24 ET

LEPU BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 21 05:54 ET

LEPU BIO-B: NOTICE OF BOARD MEETING

Aug 9 04:41 ET

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 5 21:01 ET

LEPU BIO-B: VOLUNTARY ANNOUNCEMENTBREAKTHROUGH THERAPY DESIGNATION GRANTEDBY THE FDA TO MRG003 FOR THE TREATMENT OF R/M NPC

Aug 4 20:04 ET

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 4 21:10 ET

LEPU BIO-B: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETINGHELD ON JUNE 19, 2024

Jun 19 07:57 ET

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 5 21:04 ET

LEPU BIO-B: Proxy Form for the Annual General Meeting to be held on June 19 2024

May 28 04:45 ET

LEPU BIO-B: (1) 2023 REPORT OF THE BOARD OF DIRECTORS(2) 2023 REPORT OF THE BOARD OF SUPERVISORS(3) 2023 ANNUAL REPORT(4) 2023 FINANCIAL ACCOUNTS REPORT(5) 2024 FINANCIAL BUDGET(6) 2023 ANNUAL PROFIT DISTRIBUTION PLAN(7) RE-APPOINTMENT OF AUDITOR(8) GENERAL MAN

May 28 04:39 ET